🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

18 results for “Amphastar France Pharmaceuticals” Clear

  1. Armstrong Albuterol Sulfate Inhalation Aerosol

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial

  2. E004 (Epinephrine Inhalation Aerosol) HFA-MDI

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  3. Epinephrine HFA-MDI (E004)

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  4. I004

    Amphastar France Pharmaceuticals

    Pharmacokinetics

    phase 3 small molecule active

    2 trials

  5. Placebo

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    1 trial

  6. albuterol (Armstrong Albuterol HFA)

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial

  7. albuterol HFA (Armstrong's)

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule terminated

    1 trial

  8. epinephrine inhalation aerosol

    Amphastar France Pharmaceuticals

    Asthma

    phase 3 small molecule completed

    2 trials

  9. A006

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  10. A006 DPI

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    2 trials

  11. Albuterol DPI 25 mcg/inh

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  12. Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule terminated

    1 trial

  13. Arm T1: Primatene Mist HFA

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  14. E004 (epinephrine inhalation aerosol), 90 mcg/actuation

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule terminated

    1 trial

  15. Epinephrine Inhalation Aerosol, HFA

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  16. Hyaluronidase

    Amphastar France Pharmaceuticals

    Allergic Skin Reaction

    phase 2 small molecule completed

    1 trial

  17. albuterol inhalation powder

    Amphastar France Pharmaceuticals

    Asthma

    phase 2 small molecule completed

    1 trial

  18. Epinephrine (0.125 mg/inhalation)

    Amphastar France Pharmaceuticals

    Pharmacokinetics

    approved other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources